Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Mazzarella who wrote (9101)	4/30/1998 11:29:00 AM
From: Scott H. Davis	Respond to of 14328

Richard, profits are up, revenue is accelerating, product line and distribution channels have increased dramitically over the last year due to both internal development and acquisitions. Major efforts have been made to put the company on a solid foundation in terms of capacity and cost control, and to take advantage of Ireland's very favorible business and tax climate. In summary lots of good pieces have been put into the puzzle. The risk/reward is pretty good at this point. IMSCO Scott (see TRIBYites, I CAN be positive and brief)

To: Richard Mazzarella who wrote (9101)	4/30/1998 11:44:00 AM
From: Scott H. Davis	Read Replies (1) \| Respond to of 14328

Richard, I was too brief. Technically, TRIBY bounced off support at 2 1/8, and moving up well. Since this qtr report will most likely have a very good year over year comparison, I anticipate we may re-test resistance at about 2 9/16 soon. Look at the chart in 98 - TRIBY squezed out of a wedge to the upside, and look at the pattern of fairly progresively higher lows. The 2 year highs & lows combined with the greatly improved fundimentals gives you a pretty good upside/downside risk picture. Hope this helps. BTW when I express concerns to TRIBY management, I hope it comes across that I do appreciate their efforts, and there are areas where improvements can be made/sensitivity to shareholders extended. Scott